Lobbying disclosures · Lobbying report
ABBV: second_quarter 2026 lobbying report
Part B, Part D, drug pricing and access, negotiation, federal budget issues drug pricing in federal programs, transparency, prescription drug pricing and access, beneficiary access, IRA
Follow ABBV- Became public
- Jul 20, 2026, 10:07 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 9, 2026, 9:38 AM EST
Why this is connected
Exact legal-name match: AbbVie Inc. (https://www.sec.gov/Archives/edgar/data/1551152/).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/404698bf-f0f9-4a28-86dc-ffd1b6e98e2c/","filing_uuid":"404698bf-f0f9-4a28-86dc-ffd1b6e98e2c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/404698bf-f0f9-4a28-86dc-ffd1b6e98e2c/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jennifer B. Young","dt_posted":"2026-07-20T22:07:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1299 Pennsylvania Ave NW","registrant_address_2":"FL 12","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":304736,"url":"https://lda.gov/api/v1/registrants/304736/","house_registrant_id":38067,"name":"TARPLIN, DOWNS & YOUNG, LLC","description":"Health care policy and regulatory and legislative consulting","address_1":"1299 Pennsylvania Ave NW","address_2":"FL 12","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER B. YOUNG","contact_telephone":"","dt_updated":"2026-07-28T09:23:12.888741-04:00"},"client":{"id":181309,"url":"https://lda.gov/api/v1/clients/181309/","client_id":1005142,"name":"ABBVIE INC.","general_description":"Abbvie is a global biopharmaceutical company focused on developing leading-edge therapies.","client_government_entity":false,"client_self_select":false,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-07-15"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Part B, Part D, drug pricing and access, negotiation,","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":7749,"prefix":null,"prefix_display":null,"first_name":"RAISSA","nickname":null,"middle_name":"H","last_name":"DOWNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26124,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"B","last_name":"YOUNG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61537,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":"T","last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64513,"prefix":null,"prefix_display":null,"first_name":"CHARLOTTE","nickname":null,"middle_name":"SPEARS","last_name":"IVANCIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65078,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71297,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"H","last_name":"MURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141160,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":"MEG","middle_name":null,"last_name":"JOSEPH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141752,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"FISE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147125,"prefix":"mr","prefix_display":"MR.","first_name":"PARICK","nickname":null,"middle_name":"BRAERTON","last_name":"CARROLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"federal budget issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141752,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"FISE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147125,"prefix":"mr","prefix_display":"MR.","first_name":"PARICK","nickname":null,"middle_name":"BRAERTON","last_name":"CARROLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26124,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"B","last_name":"YOUNG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7749,"prefix":null,"prefix_display":null,"first_name":"RAISSA","nickname":null,"middle_name":"H","last_name":"DOWNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61537,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":"T","last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64513,"prefix":null,"prefix_display":null,"first_name":"CHARLOTTE","nickname":null,"middle_name":"SPEARS","last_name":"IVANCIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65078,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71297,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"H","last_name":"MURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141160,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":"MEG","middle_name":null,"last_name":"JOSEPH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"drug pricing in federal programs, transparency, prescription drug pricing and access, beneficiary access, IRA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":7749,"prefix":null,"prefix_display":null,"first_name":"RAISSA","nickname":null,"middle_name":"H","last_name":"DOWNS","suffix":null,"suffix_display":null},"covered_position":"Prin. Dep. Asst. Sec for Leg.-HHS; Dep. Asst. Sec. for Leg.-HSS; Staff Dir., Sub Cmte. on Employment, Sen. HELP Cmte.","new":false},{"lobbyist":{"id":26124,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"B","last_name":"YOUNG","suffix":null,"suffix_display":null},"covered_position":"Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance","new":false},{"lobbyist":{"id":61537,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":"T","last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":"Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham","new":false},{"lobbyist":{"id":64513,"prefix":null,"prefix_display":null,"first_name":"CHARLOTTE","nickname":null,"middle_name":"SPEARS","last_name":"IVANCIC","suffix":null,"suffix_display":null},"covered_position":"Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner","new":false},{"lobbyist":{"id":65078,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Sen. HELP Cmte.; Staff Dir., Sen. HELP Cmte.; Counsel to Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun","new":false},{"lobbyist":{"id":71297,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"H","last_name":"MURRY","suffix":null,"suffix_display":null},"covered_position":"Staff Dir., Sub. Cmte. on Helath, Ways and Means Cmte; Sr. Policy Adivsor, Maj. Leader McCarthy; Policy Advisor, Maj. Whip McCarthy; Prof. Staff, Republicans Study Cmte.; Leg. Aide, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price","new":false},{"lobbyist":{"id":141160,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":"MEG","middle_name":null,"last_name":"JOSEPH","suffix":null,"suffix_display":null},"covered_position":"CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte.","new":false},{"lobbyist":{"id":141752,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"FISE","suffix":null,"suffix_display":null},"covered_position":"Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform","new":false},{"lobbyist":{"id":147125,"prefix":"mr","prefix_display":"MR.","first_name":"PARICK","nickname":null,"middle_name":"BRAERTON","last_name":"CARROLL","suffix":null,"suffix_display":null},"covered_position":"Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Price change after we could observe it
+0.37% ABBV
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in ABBV
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Oct 7, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 18, 2026$15K–$50K
Rep. Pete Sessions (R-TX-17)
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 18, 2026
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 3, 2026$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded May 5, 2026 · disclosed Jun 3, 2026 · Joint
- Feb 6, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 15, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 15, 2026 · Joint
- Jan 13, 2026$1K–$15K
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.